Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
James R. Hagman, PhD, is a researcher at National Jewish Health. Dr. Hagman is in the Department of Biomedical Research. 1989 University of Washington, Seattle, PhD, Microbiology.1986 University of Washington, Seattle, MS, Microbiology.1979 University of California, Berkeley, BA, Genetics. His research interests are Regulation of B cell transcription and development Lymphocyte differentiation proceeds through multiple stages characterized by the expression of distinct sets of genes. My laboratory’s goals include understanding how the nuclear proteins Early B cell Factor (EBF) and Pax5 (B cell-specific activator protein) regulate B lineage specification, commitment and the immune response to antigens. EBF has been identified as a crucial factor for lineage determination.
Antibodies, B Cells, Epigenetics, Gene Expression, Leukemia/Lymphoma and Immunology